| Literature DB >> 23287865 |
Samuel C C Chiang1, Jakob Theorell, Miriam Entesarian, Marie Meeths, Monika Mastafa, Waleed Al-Herz, Per Frisk, Kimberly C Gilmour, Marianne Ifversen, Cecilia Langenskiöld, Maciej Machaczka, Ahmed Naqvi, Jeanette Payne, Antonio Perez-Martinez, Magnus Sabel, Ekrem Unal, Sule Unal, Jacek Winiarski, Magnus Nordenskjöld, Hans-Gustaf Ljunggren, Jan-Inge Henter, Yenan T Bryceson.
Abstract
Cytotoxic lymphocytes, encompassing cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, kill pathogen-infected, neoplastic, or certain hematopoietic cells through the release of perforin-containing lytic granules. In the present study, we first performed probability-state modeling of differentiation and lytic granule markers on CD8(+) T cells to enable the comparison of bona fide CTLs with NK cells. Analysis identified CD57(bright) expression as a reliable phenotype of granule marker-containing CTLs. We then compared CD3(+)CD8(+)CD57(bright) CTLs with NK cells. Healthy adult peripheral blood CD3(+)CD8(+)CD57(bright) CTLs expressed more granzyme B but less perforin than CD3(-)CD56(dim) NK cells. On stimulation, such CTLs degranulated more readily than other T-cell subsets, but had a propensity to degranulate that was similar to NK cells. Remarkably, the CTLs produced cytokines more rapidly and with greater frequency than NK cells. In patients with biallelic mutations in UNC13D, STX11, or STXBP2 associated with familial hemophagocytic lymphohistiocytosis, CTL and NK cell degranulation were similarly impaired. Therefore, cytotoxic lymphocyte subsets have similar requirements for Munc13-4, syntaxin-11, and Munc18-2 in lytic granule exocytosis. The present results provide a detailed comparison of human CD3(+)CD8(+)CD57(bright) CTLs and NK cells and suggest that analysis of CD57(bright) CTL function may prove useful in the diagnosis of primary immunodeficiencies including familial hemophagocytic lymphohistiocytosis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23287865 DOI: 10.1182/blood-2012-07-442558
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113